Christoph T. Salat - Publications

Surgical axillary intervention after neoadjuvant systemic therapy (NST) for early-stage breast cancer - Clinical significance of micrometastases: Data from five neoadjuvant studies.

Journal: Breast (Edinburgh, Scotland)

Published: January 05, 2026

Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial.

Journal: Oncology research and treatment

Published: September 19, 2024

Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 18, 2022

Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.

Journal: NPJ breast cancer

Published: November 09, 2022

Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 01, 2020

Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: January 11, 2020

Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.

Journal: Breast care (Basel, Switzerland)

Published: November 18, 2019

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial.

Journal: International journal of cancer

Published: December 17, 2018

Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study.

Journal: Frontiers in pharmacology

Published: November 21, 2018

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 19, 2018

Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.

Journal: Breast cancer research : BCR

Published: August 22, 2018

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.

Journal: BMC medicine

Published: April 10, 2018